Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Waters

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
Circulation|December 3, 2020
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment ComparisonsBernard R Chaitman, Karen P Alexander, Derek D Cyr, et al.
Circulation|February 23, 2026
Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOTJean-Claude Tardif, Lambert Busque, Steve Geoffroy, et al.
Circulation. Genomic and Precision Medicine|February 9, 2021
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOTMarie-Pierre Dubé, Marc-André Legault, Audrey Lemaçon, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
The Lancet. Respiratory Medicine|May 30, 2021
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier, et al.
Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
Circulation|December 3, 2020
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment ComparisonsBernard R Chaitman, Karen P Alexander, Derek D Cyr, et al.
Circulation|February 23, 2026
Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOTJean-Claude Tardif, Lambert Busque, Steve Geoffroy, et al.
Circulation. Genomic and Precision Medicine|February 9, 2021
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOTMarie-Pierre Dubé, Marc-André Legault, Audrey Lemaçon, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
The Lancet. Respiratory Medicine|May 30, 2021
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier, et al.
Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Pageof 16